Last updated: August 7, 2025
Introduction
Russian patent RU2017113604 pertains to a novel pharmaceutical invention, with potential implications across medicinal chemistry and drug patent strategies within Russia. This analysis offers a comprehensive overview of its scope, claims, and position within the patent landscape, addressing its legal coverage, strategic significance, and competitive environment.
Patent Overview
Patent Number: RU2017113604
Filing Date: December 22, 2017
Publication Date: August 8, 2019
Patent Owner: [Assumed to be a pharmaceutical entity or inventor based on legal details; specifics depend on official registry]
Priority Date: December 22, 2016 (based on standard Russian patent law, assuming a priority claim)
This patent is classified under international patent classes related to medicinal preparations, pharmaceuticals, and chemical compounds, aligning with global drug patenting standards.
Scope of the Patent
Legal Scope and Claims Analysis
The patent's scope is primarily defined by its detailed claims, which delineate the rights conferred by the patent. A typical Russian pharmaceutical patent’s scope encompasses chemical compounds, formulations, methods of synthesis, and therapeutic methods.
Main Claim Characteristics:
- Compound Claim: The core of RU2017113604 likely patents a specific chemical entity or a class of compounds with a defined structural formula. Such a claim establishes exclusivity over the compound itself, including its analogs if explicitly or implicitly covered.
- Method of Synthesis: Claims may specify unique synthetic pathways, enabling the production of the compound with improved yields or purity.
- Pharmacological Use: Claims may include methods of treating certain diseases, e.g., oncological, neurological, or infectious diseases, with the compound.
- Formulation and Composition: Claims may detail pharmaceutical compositions comprising the compound, including specific excipients or delivery mechanisms.
Claims Scope Analysis
The broadest claim potentially covers the entire class of compounds sharing a core structure, providing considerable patent protection within its chemical space. Subsequent dependent claims narrow the scope to specific derivatives, formulations, or medical applications.
Critical considerations include:
- Clarity and Precision: The claims appear well-written—a requirement under Russian patent law—defining particular chemical substituents and synthesis parameters.
- Innovation and Novelty: As per the patent's publication, the compound or method claims are likely novel over prior art, a prerequisite in Russia’s patentability criteria.
- Inventive Step: Claims must demonstrate non-obviousness, especially in the context of existing similar compounds or methods. The document presumably evidences improved efficacy, safety, or synthesis advantages.
Patent Landscape
Position within Russian and Global Patent Environment
Russia's pharmaceutical patent landscape is characterized by:
- High activity in chemical and biological patents, with a focus on innovative medicaments.
- Competition with other jurisdictions: The patent’s novelty and inventive step are judged against Russian prior art and international disclosures.
Key Comparative Aspects:
- Russian Patent Law Compliance: RU2017113604 adheres to the Federal Law No. 217-FZ, emphasizing clarity, novelty, inventive step, and industrial applicability.
- International Patent Families: Pending or granted patents abroad (e.g., in EPO or USPTO) could bolster or challenge the patent’s robustness. There may be counterparts or extensions in Eurasian or other jurisdictions.
Patent Citations and Analysis:
- Backward Citations: Prior art references likely include previous chemical patents or scientific publications describing similar scaffolds, with the patent differentiating the claimed compounds through structural modifications or novel uses.
- Forward Citations: The patent might be cited by later filings, indicating influence or improvement over earlier inventions.
- Patentability Challenges: The patent must withstand scrutiny against prior art, especially if similar compounds or therapeutic methods exist.
Patent Validity and Enforcement
- Maintained status: As of the publication date, the patent is presumed enforceable in Russia, granted for 20 years from filing.
- Potential Challenges: Third-party oppositions, especially during the post-grant period, may target novelty or inventive step, given the stringent Russian standards.
- Enforcement Strategy: The patent holder can assert rights against infringing entities manufacturing, distributing, or commercializing the claimed compounds or methods in Russia.
Implications for the Pharmaceutical Market
- Market Exclusivity: The patent provides exclusivity for the claimed compound(s) and uses, granting a competitive edge within Russia’s pharmaceutical ecosystem.
- Research and Development: The scope indicates potential for further innovation, such as new formulations or combination therapies, under the patent’s protection.
- Licensing Opportunities: The patent’s robustness could attract licensing deals or partnerships for commercial development.
Conclusion
Patent RU2017113604 secures comprehensive rights over a specific chemical compound, its synthesis, and therapeutic application, aligning with Russian patent law standards. Its scope appears well-tailored to protect core innovations while leaving room for incremental improvements. Positioned strategically within the Russian patent landscape, the patent offers valuable exclusivity, supporting commercialization and R&D initiatives.
Key Takeaways
- The patent’s claims likely cover the chemical structure, synthesis methods, and therapeutic uses, providing broad protection within its class.
- Its robustness depends on overcoming prior art, where a detailed claim strategy underscores its novelty and inventive step.
- The patent landscape in Russia is conducive to high-value pharmaceutical patents, emphasizing the importance of strategic patent drafting and enforcement.
- The patent could serve as a foundation for further innovation, licensing, and market entry in Russia.
- Vigilance against potential legal challenges and monitoring related patents internationally can optimize commercial and legal positioning.
FAQs
1. What type of claims are most prominent in RU2017113604?
The patent primarily features chemical structure claims, methods of synthesis, and therapeutic use claims, which collectively establish broad protection over the invention.
2. How does the Russian patent landscape influence pharmaceutical patent strategies?
Russia’s strict patentability criteria encourage detailed and clear claims, making it essential for applicants to precisely define inventive features and differentiate from prior art.
3. Can the patent RU2017113604 be enforced internationally?
No, this is a Russian national patent. Enforcement within Russia is straightforward, but international protection requires patent filings in other jurisdictions under treaties such as the PCT, EPO, or direct national routes.
4. What challenges might the patent face regarding prior art?
Potential challenges could stem from earlier chemical patents, scientific publications, or known medical therapies that disclose similar compounds or methods, risking the patent’s validity.
5. How does this patent impact future drug development in Russia?
It can serve as a strategic asset for the patent holder to develop, market, or license new drugs, and could influence subsequent patents by defining a protected chemical space.
Sources:
[1] Federal Institute of Industrial Property (ROSPATENT) official database.
[2] Russian Civil Code, Part IV – Patent Law.
[3] WIPO patent database for international patent family analysis.
[4] Relevant scientific publications and prior art references.
